Bionomics Limited
OTC: BNOEF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Spyridon Papapetropoulos
- Headquarters
- Eastwood, Australia
- IPO year
- 2014
- Market cap
- $8.8M
- Website
- https://www.bionomics.com.au
Loading BNOEF…
Loading profile data…Frequently asked questions about BNOEF
What does Bionomics Limited (BNOEF) do?
Bionomics Limited, an Australian clinical-stage biopharmaceutical company founded in 1996 and based in Eastwood, focuses on identifying and developing innovative drug candidates to address central nervous system conditions and various cancers. A significant experimental medicine in their pipeline is BNC210, a negative allosteric modulator target...
Where does BNOEF trade?
Bionomics Limited (BNOEF) trades on the Other OTC.
What sector is BNOEF in?
Bionomics Limited (BNOEF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bionomics Limited?
Spyridon Papapetropoulos is the chief executive officer of Bionomics Limited (BNOEF).
Where is Bionomics Limited headquartered?
Bionomics Limited is headquartered in Australia.
Does BNOEF pay a dividend?
Bionomics Limited (BNOEF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BNOEF go public?
Bionomics Limited (BNOEF) completed its initial public offering in 2014.